EUVIMEDEUVIMED entdecken
Fallbericht

PEGYLATED LIPOSOMAL ENCAPSULATED DOXORUBICIN AND BRENTUXIMAB VEDOTIN IN STAGE IIB MYCOSIS FUNGOIDES – A CASE REPORT

ROMANIAN JOURNAL OF CLINICAL AND EXPERIMENTAL DERMATOLOGY · 2014

DOI: 10.26574/rojced.2017.4.3.126 ↗

Kurz gefasst

Fallbericht in der Zeitschrift ROMANIAN JOURNAL OF CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2014.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2014). PEGYLATED LIPOSOMAL ENCAPSULATED DOXORUBICIN AND BRENTUXIMAB VEDOTIN IN STAGE IIB MYCOSIS FUNGOIDES – A CASE REPORT. ROMANIAN JOURNAL OF CLINICAL AND EXPERIMENTAL DERMATOLOGY. https://doi.org/10.26574/rojced.2017.4.3.126

Vancouver

PEGYLATED LIPOSOMAL ENCAPSULATED DOXORUBICIN AND BRENTUXIMAB VEDOTIN IN STAGE IIB MYCOSIS FUNGOIDES – A CASE REPORT. ROMANIAN JOURNAL OF CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2014. doi:10.26574/rojced.2017.4.3.126

BibTeX
@article{euvimed2014,
  title = {PEGYLATED LIPOSOMAL ENCAPSULATED DOXORUBICIN AND BRENTUXIMAB VEDOTIN IN STAGE IIB MYCOSIS FUNGOIDES – A CASE REPORT},
  journal = {ROMANIAN JOURNAL OF CLINICAL AND EXPERIMENTAL DERMATOLOGY},
  year = {2014},
  doi = {10.26574/rojced.2017.4.3.126}
}
Kostenlos starten →